Lactose Monohydrate Market Report 2026

The lactose monohydrate market size has grown strongly in recent years. It will grow from $1.32 billion in 2025 to $1.42 billion in 2026 at a compound annual growth rate (CAGR) of 7%. The growth in the historic period can be attributed to growth of pharmaceutical tablet manufacturing, widespread use of lactose as excipient, expansion of dairy-derived ingredient processing, availability of large-scale lactose refining capacity, demand from food formulation industries.

The lactose monohydrate market size is expected to see strong growth in the next few years. It will grow to $1.83 billion in 2030 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to increasing pharmaceutical production volumes, rising demand for specialty excipients, expansion of nutraceutical manufacturing, growing focus on formulation stability, increasing adoption of co-processed excipient technologies. Major trends in the forecast period include increasing demand for pharmaceutical grade lactose, rising use in solid oral dosage formulations, growing preference for high-purity excipients, expansion of spray-dried lactose applications, enhanced focus on consistent particle size control.

The rising pharmaceutical drug production is expected to drive the growth of the lactose monohydrate market in the coming years. Pharmaceutical drug production involves the structured manufacturing of medicines under strict quality controls to ensure their safety, efficacy, and overall quality for medical use. The growth in pharmaceutical production is largely driven by the increasing aging population, which fuels demand for advanced therapies to manage chronic diseases effectively. Lactose monohydrate acts as a filler and binder in pharmaceutical formulations, promoting uniform distribution of active ingredients. Its excellent compressibility supports efficient tablet formation and consistent drug performance. For example, in June 2023, the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based trade association representing the European pharmaceutical industry, reported that total pharmaceutical production in Europe reached $422.8 billion in 2023, up from $393.85 billion in 2022. Therefore, the rising pharmaceutical drug production is driving the growth of the lactose monohydrate market.

Key companies in the lactose monohydrate market are focusing on developing advanced products, such as pharmaceutical-grade lactose, to ensure patient safety and comply with strict regulatory requirements. Pharmaceutical-grade lactose is a highly purified form of lactose designed for drug formulations, serving as a reliable excipient that ensures uniformity, safety, and compatibility with active pharmaceutical ingredients (APIs). For instance, in October 2023, Lactalis Ingredients, a France-based dairy ingredient producer, launched Lactalpha, a line of milled and sieved lactose monohydrate products. This launch marks the company’s expansion from edible lactose into the pharmaceutical sector, offering controlled particle size, excellent flowability, and high purity, making the products ideal excipients for tablets, capsules, and sachets.

In April 2025, LBB Specialties, a US-based specialty chemicals and ingredient distributor, partnered with Kerry Group to enhance access and excellence in pharmaceutical solutions. This partnership aims to expand the availability of Kerry’s premium Sheffield brand pharmaceutical-grade lactose excipients across the U.S., improving product consistency, supply chain efficiency, and innovation in life sciences formulations. Kerry Group is an Ireland-based manufacturer of pharmaceutical lactose monohydrate.

Major companies operating in the lactose monohydrate market are DFE Pharma, Kerry Group, MEGGLE GmbH & Co KG, Lactose India Limited, Lactalis Ingredients, BASF SE, Merck KGaA, Armor Pharma, Hilmar Ingredients, Glanbia plc, Fonterra Co‑operative Group Limited, Arla Foods Ingredients, Milei GmbH, Saputo Inc, Molvest Group, Tatua Co‑operative Dairy Company Ltd, Valio Ltd.

North America was the largest region in the lactose monohydrate market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lactose monohydrate market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the lactose monohydrate market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the lactose monohydrate market by increasing costs of imported dairy raw materials, processing equipment, drying systems, and pharmaceutical-grade refining technologies. Europe and North America are particularly affected due to reliance on cross-border lactose trade and specialized processing infrastructure, while Asia-Pacific faces cost pressure on pharmaceutical-grade imports. These tariffs are elevating input costs and influencing pricing across pharmaceutical and food applications. However, they are also encouraging regional dairy processing expansion, local excipient manufacturing, and supply chain diversification for lactose-based ingredients.

The lactose monohydrate market research report is one of a series of new reports that provides lactose monohydrate market statistics, including lactose monohydrate industry global market size, regional shares, competitors with a lactose monohydrate market share, detailed lactose monohydrate market segments, market trends and opportunities, and any further data you may need to thrive in the lactose monohydrate industry. This lactose monohydrate market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Lactose monohydrate is a crystalline form of lactose containing one molecule of water per molecule of lactose. It is a disaccharide sugar derived from milk, composed of glucose and galactose. Commonly used as a filler or stabilizer in pharmaceutical tablets and food products, it is valued for its compressibility and solubility. This form of lactose is widely used due to its stability and ease of handling.

The primary product types of lactose monohydrate include crystalline lactose monohydrate and amorphous lactose monohydrate. Crystalline lactose monohydrate is a stable, structured form of lactose appreciated in pharmaceuticals and food for its flowability, compressibility, mild sweetness, and solubility. It is available in various purities, such as food grade and pharmaceutical grade, and is distributed through channels including online stores, supermarkets or hypermarkets, specialty stores, and others. Key applications include pharmaceuticals, food and beverages, nutraceuticals, cosmetics and personal care, and animal feed.

The lactose monohydrate market consists of sales of milled lactose monohydrate, sieved lactose monohydrate, spray-dried lactose monohydrate, and crystalline lactose monohydrate. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.